Is a complete LON/0RA9 research report available?

No complete published report is available for lon/0RA9 (LON/0RA9) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0RA9 (LON/0RA9)

London Stock Exchange: LON/0RA9 · EUR

€101

+0.90 (+0.9%)· Recorded snapshot

Market cap	7.6B
Revenue (ttm)	4.3M
Net income (ttm)	-290.1M
EPS (ttm)	-€3.95
Volume	845
Beta	-0.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.3M
Net income (ttm): -290.1M
EPS (ttm): -€3.95
Market cap: 7.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-12 02:00 UTC

All LON/0RA9 indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

EUR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	80
Employees Change	5%
Employees Change Percent	8.06
Enterprise value	EUR 7.2B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0012333284
Last refreshed	2026-09-12
Market cap	EUR 7.6B
Price	EUR 101
Price currency	EUR
Rev Per Employee	53,700.29x
Sector	Healthcare
Sector PE	20.64
Sector PE Fwd	13.38
Sic	2836
Symbol	lon/0RA9
Website	https://www.abivax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.83%
FCF yield	-2.06%
P/B ratio	20.2x
P/S ratio	1,763.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 4.3M
Gross Profit Growth	-59.82%
Gross Profit Growth Q	35.21%
Gross Profit Growth3 Y	3.13%
Net Income	EUR -290.1M
Net Income Growth Years	0%
Pretax Margin	-6,628.54%
Profit Per Employee	EUR -3.6M
ROA	-44.65
Roa5y	-37.56
ROCE	-52.6
ROE	-157.1
Roe5y	-198.1
ROIC	-56.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	35.89%
Cagr3y	82%
Cagr5y	23.71%
EPS Growth Years	0
Revenue Growth	-59.82x
Revenue Growth Q	35.21x
Revenue Growth Qo Q	-29.78x
Revenue Growth Years	0x
Revenue Growth3 Y	3.13x
Revenue Growth5 Y	222.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 477.8M
Cash	EUR 429.2M
Current Assets	EUR 440.1M
Current Liabilities	EUR 53.4M
Debt	EUR 29.9M
Debt Equity	EUR 0.08
Debt FCF	EUR -0.19
Equity	EUR 375.1M
Interest Coverage	-9.63
Liabilities	EUR 102.6M
Long Term Assets	EUR 37.6M
Long Term Liabilities	EUR 49.3M
Net Cash	EUR 399.3M
Net Cash By Market Cap	EUR 5.27
Net Debt Equity	EUR -1.06
Tangible Book Value	EUR 353.3M
Tangible Book Value Per Share	EUR 4.46
WACC	3.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.25
Net Working Capital	EUR -34.5M
Quick ratio	8.07
Working Capital	EUR 393.8M
Working Capital Turnover	EUR 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	35.86%
200-day SMA	102.9
3Y total return	503.11%
50-day SMA	108.7
50-day SMA vs 200-day SMA	50over200
5Y total return	189.76%
All Time High	139
All Time High Change	-27.77%
All Time High Date	2026-07-03
All Time Low	4.57
All Time Low Change	2,096.94%
All Time Low Date	2025-04-07
ATR	3.03
Beta	-0.25
Ch YTD	-16.19
High	101.3
High52	139
High52 Date	2026-07-03
High52ch	-27.12%
Low	98.65
Low52	60.7
Low52 Date	2026-06-03
Low52ch	66.89%
Ma50ch	-7.67%
Price vs 200-day SMA	-2.44%
RSI	46.63
RSI Monthly	64.83
RSI Weekly	49.53
Sharpe ratio	0.86x
Sharpe Ratio3y	0.64x
Sharpe Ratio5y	0.5x
Sortino ratio	1.27
Sortino Ratio3y	4.17
Sortino Ratio5y	2.59
Total Return	-16.25%
Tr YTD	-16.19
Tr1m	-10.2%
Tr1w	0.75%
Tr3m	15.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	76,362,248%
Net Borrowing	-46,158,977.6
Shares Insiders	0.57%
Shares Institutions	91.25%
Shares Qo Q	0.96%
Shares Yo Y	16.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -202.4M
Adjusted OCF	-202,304,255
Average Volume	1,970.65x
Bv Per Share	4.73
CAPEX	EUR -132,723
Ch1m	-10.2
Ch1w	0.75
Ch1y	35.86
Ch3m	15.2
Ch3y	503.1
Ch5y	189.8
Ch6m	0.6
Change	0.9%
Change From Open	2.63
Close	100.4
Days Gap	-1.69
Depreciation Amortization	926,232.7
Dollar Volume	85,598.5
Earnings Date	2026-09-21
EBIT	EUR -222.7M
EBITDA	EUR -221.8M
EPS	EUR -3.95
F Score	3
FCF	EUR -155.9M
FCF EV Yield	-2.17x
Financing CF	484,801,811
Fiscal Year End	December
Founded	2,013
Goodwill	15,796,555.5
Income Tax	EUR 5.3M
Investing CF	-7,666,480
Is Primary Listing	0
Last Earnings Date	2026-05-22
Last Report Date	2026-03-31
Ma150	102.7
Ma150ch	-2.19%
Ma20	99.97
Ma20ch	0.43%
Net CF	326,433,993
Next Earnings Date	2026-09-21
Open	98.7
Position In Range	100
Ppne	1,529,141.6
Price Date	2026-09-11
Ptbv Ratio	21.45
Relative Volume	0.43x
Revenue	4,296,023x
SBC By Revenue	1,083.7x
Share Based Comp	46,555,964
Tax By Revenue	123.5x
Tr6m	0.6%
Volume	845
Z Score	22.21

LON/0RA9 (LON/0RA9)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0RA9

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0RA9 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0RA9

Frequently asked questions